Related references
Note: Only part of the references are listed.A systematic literature review of drug therapies for the treatment of psoriatic arthritis: current evidence and meta-analysis informing the EULAR recommendations for the management of psoriatic arthritis
Zoe Ash et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
A Pilot Study of an Oral Phosphodiesterase Inhibitor (Apremilast) for Atopic Dermatitis in Adults
Aman Samrao et al.
ARCHIVES OF DERMATOLOGY (2012)
Efficacy and safety of biologics in erythrodermic psoriasis: a multicentre, retrospective study
M. Viguier et al.
BRITISH JOURNAL OF DERMATOLOGY (2012)
Etanercept suppresses regenerative hyperplasia in psoriasis by acutely downregulating epidermal expression of interleukin (IL)-19, IL-20 and IL-24
F. Wang et al.
BRITISH JOURNAL OF DERMATOLOGY (2012)
Regulatory T Cells Expressing PPAR-γ Control Inflammation in Obesity
Masahide Hamaguchi et al.
CELL METABOLISM (2012)
Molecular and clinical rationale for therapeutic targeting of interleukin-5 and its receptor
N. A. Molfino et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2012)
Systemic treatment of adult atopic dermatitis
Hannah Cookson et al.
CLINICAL MEDICINE (2012)
Abnormal epidermal barrier in the pathogenesis of atopic dermatitis
Ronni Wolf et al.
CLINICS IN DERMATOLOGY (2012)
Abnormal epidermal barrier in the pathogenesis of contact dermatitis
Ehrhardt Proksch et al.
CLINICS IN DERMATOLOGY (2012)
Evidences of efficacy of allergen immunotherapy in atopic dermatitis: an updated review
Enrico Compalati et al.
CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY (2012)
Update on systemic therapies for atopic dermatitis
Kristopher S. Denby et al.
CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY (2012)
Increased frequencies of IL-31-producing T cells are found in chronic atopic dermatitis skin
Krisztina Szegedi et al.
EXPERIMENTAL DERMATOLOGY (2012)
The role of tocilizumab in the management of rheumatoid arthritis
Zoe Ash et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2012)
Filaggrin mutations and atopy: consequences for future therapeutics
Jennifer Heimall et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2012)
Treatment of severe refractory adult atopic dermatitis with ustekinumab
Rafael Puya et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2012)
The safety and efficacy of sublingual and oral immunotherapy for milk allergy
Corinne A. Keet et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2012)
IL-17A is essential for cell activation and inflammatory gene circuits in subjects with psoriasis
James G. Krueger et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2012)
IL-31 regulates differentiation and filaggrin expression in human organotypic skin models
Christian Cornelissen et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2012)
Altered stratum corneum barrier and enhanced percutaneous immune responses in filaggrin-null mice
Hiroshi Kawasaki et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2012)
The persistence of atopic dermatitis and filaggrin (FLG) mutations in a US longitudinal cohort
David J. Margolis et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2012)
Epigenetic modifications and improved regulatory T-cell function in subjects undergoing dual sublingual immunotherapy
Ravi S. Swamy et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2012)
Early suppression of basophil activation during allergen-specific immunotherapy by histamine receptor 2
Natalija Novak et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2012)
Th1 cytokines accentuate but Th2 cytokines attenuate ceramide production in the stratum corneum of human epidermal equivalents: An implication for the disrupted barrier mechanism in atopic dermatitis
Eri Sawada et al.
JOURNAL OF DERMATOLOGICAL SCIENCE (2012)
Does p40-targeted therapy represent a significant evolution in the management of plaque psoriasis?
Christopher E. M. Griffiths et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2012)
Brodalumab, an Anti-Interleukin-17-Receptor Antibody for Psoriasis
Kim A. Papp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Anti-Interleukin-17 Monoclonal Antibody Ixekizumab in Chronic Plaque Psoriasis
Craig Leonardi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
IL-31 significantly correlates with disease activity and Th2 cytokine levels in children with atopic dermatitis
Ulrike Raap et al.
PEDIATRIC ALLERGY AND IMMUNOLOGY (2012)
Epidermal Barrier in Atopic Dermatitis
Byung Eui Kim et al.
ALLERGY ASTHMA & IMMUNOLOGY RESEARCH (2012)
Atopic dermatitis - from new pathophysiologic insights to individualized therapy
N. Novak et al.
ALLERGY (2011)
Anti-interleukin-5 antibody therapy in asthma and allerges
Jonathan Corren
CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY (2011)
Advances in atopic dermatitis
Natalija Novak et al.
CURRENT OPINION IN IMMUNOLOGY (2011)
IL-17 producing cells in host defense and atopy
Joshua D. Milner
CURRENT OPINION IN IMMUNOLOGY (2011)
Association of polymorphisms in genes encoding IL-4, IL-13 and their receptors with atopic dermatitis in a Korean population
Jung-Hyun Namkung et al.
EXPERIMENTAL DERMATOLOGY (2011)
Combined occurrence of filaggrin mutations and IL-10 or IL-13 polymorphisms predisposes to atopic dermatitis
Aleksandra Lesiak et al.
EXPERIMENTAL DERMATOLOGY (2011)
Atopic dermatitis: a disease of altered skin barrier and immune dysregulation
Mark Boguniewicz et al.
IMMUNOLOGICAL REVIEWS (2011)
Pharmacokinetic/pharmacodynamic analyses of chymase inhibitor SUN13834 in NC/Nga mice and prediction of effective dosage for atopic dermatitis patients
Atsuto Ogata et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2011)
Contrasting pathogenesis of atopic dermatitis and psoriasis-Part II: Immune cell subsets and therapeutic concepts
Emma Guttman-Yassky et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2011)
Nonlesional atopic dermatitis skin is characterized by broad terminal differentiation defects and variable immune abnormalities
Mayte Suarez-Farinas et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2011)
A randomized, placebo-controlled, dose-ranging study of single-dose omalizumab in patients with H1-antihistamine-refractory chronic idiopathic urticaria
Sarbjit Saini et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2011)
Mechanisms of allergen-specific immunotherapy
Cezmi A. Akdis et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2011)
Interrupting IL-6-receptor signaling improves atopic dermatitis but associates with bacterial superinfection
Alexander A. Navarini et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2011)
Contrasting pathogenesis of atopic dermatitis and psoriasis-Part I: Clinical and pathologic concepts
Emma Guttman-Yassky et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2011)
A randomized controlled study of peanut oral immunotherapy: Clinical desensitization and modulation of the allergic response
Pooja Varshney et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2011)
Natural peroxisome proliferator-activated receptor-alpha agonist cream demonstrates similar therapeutic response to topical steroids in atopic dermatitis
Clarence De Belilovsky et al.
JOURNAL OF DERMATOLOGICAL TREATMENT (2011)
Preclinical Evaluation of Local JAK1 and JAK2 Inhibition in Cutaneous Inflammation
Jordan S. Fridman et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2011)
TNF-α Downregulates Filaggrin and Loricrin through c-Jun N-terminal Kinase: Role for TNF-α Antagonists to Improve Skin Barrier
Byung Eui Kim et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2011)
Integrative Responses to IL-17 and TNF-α in Human Keratinocytes Account for Key Inflammatory Pathogenic Circuits in Psoriasis
Andrea Chiricozzi et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2011)
MECHANISMS OF DISEASE Filaggrin Mutations Associated with Skin and Allergic Diseases
Alan D. Irvine et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Etanercept: An Evolving Role in Psoriasis and Psoriatic Arthritis
Srdjan Prodanovich et al.
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2010)
Current status and new developments in the treatment of psoriasis and psoriatic arthritis with biological agents
Wolfgang Weger
BRITISH JOURNAL OF PHARMACOLOGY (2010)
IL-17 and IL-22 in atopic allergic disease
Yuri Souwer et al.
CURRENT OPINION IN IMMUNOLOGY (2010)
What's new in atopic eczema?
Sabine Gisela Ploetz et al.
EXPERT OPINION ON EMERGING DRUGS (2010)
Investigational and Unproven Therapies in Atopic Dermatitis
Peck Y. Ong et al.
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA (2010)
Activation of human eosinophils and epidermal keratinocytes by Th2 cytokine IL-31: implication for the immunopathogenesis of atopic dermatitis
Phyllis Fung-Yi Cheung et al.
INTERNATIONAL IMMUNOLOGY (2010)
Phosphodiesterase 4B is essential for TH2-cell function and development of airway hyperresponsiveness in allergic asthma
S. -L. Catherine Jin et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2010)
Recent insights into atopic dermatitis and implications for management of infectious complications
Mark Boguniewicz et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2010)
Effect of filaggrin breakdown products on growth of and protein expression by Staphylococcus aureus
Helen Miajlovic et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2010)
Extrinsic and intrinsic types of atopic dermatitis
Yoshiki Tokura
JOURNAL OF DERMATOLOGICAL SCIENCE (2010)
IL-4 Regulates Skin Homeostasis and the Predisposition toward Allergic Skin Inflammation
Sarita Sehra et al.
JOURNAL OF IMMUNOLOGY (2010)
Analysis of four prevalent filaggrin mutations (R501X, 2282del4, R2447X and S3247X) in Austrian and German patients with atopic dermatitis
E. K. Greisenegger et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2010)
Comparison of Ustekinumab and Etanercept for Moderate-to-Severe Psoriasis
Christopher E. M. Griffiths et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Expansion of FOXP3-positive CD4+CD25+ T cells associated with disease activity in atopic dermatitis
Yasunori Ito et al.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2009)
Thymic stromal lymphopoietin, OX40-ligand, and interleukin-25 in allergic responses
Y. -H. Wang et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2009)
Filaggrin in atopic dermatitis (Reprinted from J Allergy Clin Immunol vol 122, pg 689-93, 2008)
Grainne M. O'Regan et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2009)
Broad defects in epidermal cornification in atopic dermatitis identified through genomic analysis
Emma Guttman-Yassky et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2009)
IL-22-producing T22 T cells account for upregulated IL-22 in atopic dermatitis despite reduced IL-17-producing TH17 T cells
Kristine E. Nograles et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2009)
IL-17 in atopic eczema: Linking allergen-specific adaptive and microbial-triggered innate immune response
Kilian Eyerich et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2009)
Effective treatment of psoriasis with etanercept is linked to suppression of IL-17 signaling, not immediate response TNF genes
Lisa C. Zaba et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2009)
Epidermal Barrier Dysfunction in Atopic Dermatitis
Michael J. Cork et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2009)
IL-22 and IL-20 are key mediators of the epidermal alterations in psoriasis while IL-17 and IFN-γ are not
Kerstin Wolk et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2009)
Mechanisms of Disease: Interleukin-17 and Type 17 Helper T Cells.
Pierre Miossec et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Mechanisms of Disease: Psoriasis.
Frank O. Nestle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
A retrospective case series review of the peroxisome proliferator-activated receptor ligand rosiglitazone in the treatment of atopic dermatitis
Ramona Behshad et al.
ARCHIVES OF DERMATOLOGY (2008)
Loricrin and involucrin expression is down-regulated by Th2 cytokines through STAT-6
Byung Eui Kim et al.
CLINICAL IMMUNOLOGY (2008)
From conventional to cutting edge: the new era of biologics in treatment of psoriasis
Julia Tzu et al.
DERMATOLOGIC THERAPY (2008)
Oral chymase inhibitor SUN13834 ameliorates skin inflammation as well as pruritus in mouse model for atopic dermatitis
Maki Terakawa et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2008)
The recombinant humanized anti-IL-6 receptor antibody tocilizumab, an innovative drug for the treatment of rheumatoid arthritis
Yoshiyuki Ohsugi et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2008)
Alefacept (lymphocyte function-associated molecule 3/IgG fusion protein) treatment for atopic eczema
Dagmar Simon et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2008)
Increased activation-induced cell death of high IFN-γ-producing TH1 cells as a mechanism of TH2 predominance in atopic diseases
Tunc Akkoc et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2008)
Anti-CD20 (rituximab) treatment for atopic eczema
Anna Sediva et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2008)
Administration of oral vitamin D induces cathelicidin production in atopic individuals
Tissa R. Hata et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2008)
Atopic dermatitis: Therapeutic concepts evolving from new pathophysiologic insights
Thomas Jung et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2008)
Anti-CD20 (rituximab) treatment improves atopic eczema
Dagmar Simon et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2008)
Anti-IL-5 (mepolizumab) therapy reduces eosinophil activation ex vivo and increases IL-5 and IL-5 receptor levels
Miguel L. Stein et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2008)
Meta-analysis of clinical trials of probiotics for prevention and treatment of pediatric atopic dermatitis
Joohee Lee et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2008)
Low Expression of the IL-23/Th17 Pathway in Atopic Dermatitis Compared to Psoriasis
Emma Guttman-Yassky et al.
JOURNAL OF IMMUNOLOGY (2008)
Efalizumab therapy for atopic dermatitis causes marked increases in circulating effector memory CD4+ T cells that express cutaneous lymphocyte antigen
Erin G. Harper et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2008)
IL-4 suppresses the recovery of cutaneous permeability barrier functions in vivo
Rieko Kurahashi et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2008)
Possible Pathogenic Role of Th17 Cells for Atopic Dermatitis
Chizuko Koga et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2008)
Th2 cytokines act on S100/A11 to downregulate keratinocyte differentiation
Michael D. Howell et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2008)
Blockade of CD11a by efalizurnab in psoriasis patients induces a unique state of T-cell hyporesponsiveness
Emma Guttman-Yassky et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2008)
Alefacept for moderate to severe atopic dermatitis: A pilot study in adults
Danielle K. Moul et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2008)
Guidelines of care for the management of psoriasis and psoriatic arthritis - Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics
Alan Menter et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2008)
Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1)
Craig L. Leonardi et al.
LANCET (2008)
Real life experience confirms sustained response to long-term biologics and switching in ankylosing spondylitis
L. C. Coates et al.
RHEUMATOLOGY (2008)
Maintenance of infliximab treatment in ankylosing spondylitis
Maxime Breban et al.
ARTHRITIS AND RHEUMATISM (2008)
Amelioration of epidermal hyperplasia by TNF inhibition is associated with reduced Th17 responses
Lisa C. Zaba et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Effect of an interieukin-4 variant on late phase asthmatic response to allergen challenge in asthmatic patients: results of two phase 2a studies
Sally Wenzel et al.
LANCET (2007)
Biologic treatment of rheumatoid arthritis and the risk of malignancy - Analyses from a large US observational study
Frederick Wolfe et al.
ARTHRITIS AND RHEUMATISM (2007)
Thymic stromal lymphopoietin and OX40 ligand pathway in the initiation of dendritic cell-mediated allergic inflammation
Yong-Jun Liu
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2007)
Sublingual immunotherapy in mite-sensitized children with atopic dermatitis: A randomized, double-blind, placebo-controlled study
Giovanni B. Pajno et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2007)
Pathogenesis and therapy of psoriasis
Michelle A. Lowes et al.
NATURE (2007)
Interleukin-22, a TH17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis
Yan Zheng et al.
NATURE (2007)
Clinical and immunopathologic findings during treatment of recalcitrant atopic eczema with efalizumab
Akmal S. Hassan et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2007)
Antagonism of IL-4 signaling by a phosphodiesterase-4 inhibitor, rolipram, in human T cells
Tzvetanka Petrova Markova et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2007)
Crohn's disease - A review of current treatment with a focus on biologics
Julian Panes et al.
DRUGS (2007)
Evaluation and management of severe asthma
Mina Gaga et al.
CURRENT MEDICINAL CHEMISTRY (2007)
Usefulness of specific immunotherapy in patients with atopic dermatitis and allergic sensitization to house dust mites:: a multi-centre, randomized, dose-response study
T Werfel et al.
ALLERGY (2006)
No effect of anti-interleukin-5 therapy (mepolizumab) on the atopy patch test in atopic dermatitis patients
J. M. Oldhoff et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2006)
TNF inhibition rapidly down-regulates multiple proinflammatory pathways in psoriasis plaques
AB Gottlieb et al.
JOURNAL OF IMMUNOLOGY (2005)
Etanercept is minimally effective in 2 children with atopic dermatitis
RL Buka et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2005)
Failure of omalizumab for treatment of severe adult atopic dermatitis
RA Krathen et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2005)
Atopic dermatitis
HC Williams
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Anti-IL-5 recombinant humanized monoclonal antibody (Mepolizumab) for the treatment of atopic dermatitis
JM Oldhoff et al.
ALLERGY (2005)
Ceramide profiles of the uninvolved skin in atopic dermatitis and psoriasis are comparable to those of healthy skin
H Farwanah et al.
ARCHIVES OF DERMATOLOGICAL RESEARCH (2005)
Interleukin-4 suppresses the enhancement of ceramide synthesis and cutaneous permeability barrier functions induced by tumor necrosis factor-α and interferon-γ in human epidermis
Y Hatano et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2005)
IL-22 inhibits epidermal differentiation and induces proinflammatory gene expression and migration of human keratinocytes
K Boniface et al.
JOURNAL OF IMMUNOLOGY (2005)
Infliximab in the treatment of moderate to severe atopic dermatitis
A Jacobi et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2005)
Alefacept reduces infiltrating T cells, activated dendritic cells, and inflammatory genes in psoriasis vulgaris
F Chamian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice
SR Dillon et al.
NATURE IMMUNOLOGY (2004)
Monoclonal anti-interleukin-5 treatment suppresses eosinophil but not T-cell functions
C Büttner et al.
EUROPEAN RESPIRATORY JOURNAL (2003)
Endogenous antimicrobial peptides and skin infections in atopic dermatitis
PY Ong et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Randomized comparison of the type 4 phosphodiesterase inhibitor cipamfylline cream, cream vehicle and hydrocortisone 17-butyrate cream for the treatment of atopic dermatitis
CEM Griffiths et al.
BRITISH JOURNAL OF DERMATOLOGY (2002)
Flow cytometric analysis of IL-4, IL-13 and IFN-γ expression in peripheral blood mononuclear cells and detection of circulating IL-13 in patients with atopic dermatitis provide evidence for the involvement of type 2 cytokines in the disease
K Kaminishi et al.
JOURNAL OF DERMATOLOGICAL SCIENCE (2002)
Efficacy of soluble IL-4 receptor for the treatment of adults with asthma
LC Borish et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2001)
Peroxisome proliferator-activated receptors in inflammation control
P Delerive et al.
JOURNAL OF ENDOCRINOLOGY (2001)
Probiotics in primary prevention of atopic disease:: a randomised placebo-controlled trial
M Kalliomäki et al.
LANCET (2001)
IL-5-induced airway eosinophilia - the key to asthma?
E Hamelmann et al.
IMMUNOLOGICAL REVIEWS (2001)
PPAR-gamma dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation
A Chawla et al.
NATURE MEDICINE (2001)
Interleukin 4 receptor α chain polymorphism Gln551Arg is associated with adult atopic dermatitis in Japan
N Oiso et al.
BRITISH JOURNAL OF DERMATOLOGY (2000)
Share Paper
